Overview
Hiromichi Matsushita practices in Tokyo, Japan. Matsushita is highly rated in 3 conditions, according to our data. Their top areas of expertise are Ascites, Acute Promyelocytic Leukemia, Leukemia, and Acute Myeloid Leukemia (AML).
Their clinical research consists of co-authoring 103 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Promyelocytic LeukemiaMatsushita isAdvanced. Learn about Acute Promyelocytic Leukemia.
- AscitesMatsushita isAdvanced. Learn about Ascites.
- LeukemiaMatsushita isAdvanced. Learn about Leukemia.
- Experienced
- Acute Megakaryoblastic LeukemiaMatsushita isExperienced. Learn about Acute Megakaryoblastic Leukemia.
- Acute Monoblastic Leukemia (AmoL)Matsushita isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myeloid Leukemia (AML)Matsushita isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult T-Cell LeukemiaMatsushita isExperienced. Learn about Adult T-Cell Leukemia.
- Angioimmunoblastic T-cell LymphomaMatsushita isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- B-Cell LymphomaMatsushita isExperienced. Learn about B-Cell Lymphoma.